Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Alignment Healthcare (ALHC) EBITDA Margin (2020 - 2025)

Alignment Healthcare (ALHC) has disclosed EBITDA Margin for 6 consecutive years, with 260.42% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBITDA Margin rose 35932.0% year-over-year to 260.42%, compared with a TTM value of 1.25% through Dec 2025, up 2849.0%, and an annual FY2025 reading of 93.37%, up 70.0% over the prior year.
  • EBITDA Margin was 260.42% for Q4 2025 at Alignment Healthcare, up from 1.58% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 260.42% in Q4 2025 and bottomed at 98.9% in Q4 2024.
  • Average EBITDA Margin over 5 years is 4.56%, with a median of 5.83% recorded in 2023.
  • The sharpest move saw EBITDA Margin crashed -9115bps in 2024, then surged 35932bps in 2025.
  • Year by year, EBITDA Margin stood at 32.74% in 2021, then plummeted by -140bps to 13.21% in 2022, then surged by 41bps to 7.75% in 2023, then crashed by -1176bps to 98.9% in 2024, then surged by 363bps to 260.42% in 2025.
  • Business Quant data shows EBITDA Margin for ALHC at 260.42% in Q4 2025, 1.58% in Q3 2025, and 2.93% in Q2 2025.